SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.52-8.7%Jan 23 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (10602)2/24/2004 10:37:48 PM
From: Biomaven  Read Replies (1) of 52153
 
Hey - by '18 XOM will long since have been munched by a diversifying MSFT. <g>

Hard to know if the majors aren't going to be like the pharma - running as fast as they can to avoid going backwards. Both are dealing with valuable but declining assets (limited by known oil reserves and patent life respectively). The biotechs presumably get matched with the independent producers, and the biotech tool companies with the oil service industry.

Imports from Canada, anyone? <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News